%0 Journal Article
%T GATA4 and DcR1 methylation in glioblastomas
%A Paulina Vaitkiene
%A Daina Skiriute
%A Kestutis Skauminas
%A Arimantas Tamasauskas
%J Diagnostic Pathology
%D 2013
%I BioMed Central
%R 10.1186/1746-1596-8-7
%X Methylation status of GATA4 and DcR1 promoters was investigated by methylation specific PCR in 99 glioblastoma patients. Statistical analyses were conducted to investigate the association between clinical variables and overall survival time.GATA4 and DcR1 were aberrantly methylated in 23.2% and 27.6% of glioblastoma tumors, but not in normal brain. GATA4 promoter hypermethylation showed significant association with patients age (p = 0.027). Relationship between genes promoter methylation and glioblastoma patient survival was not determined.The present work demonstrated that GATA4 and DcR1 promoter hypermethylation is tumor specific event in glioblastoma but they promoter methylation cannot be considered as a prognostic marker of glioblastoma survival. Virtual slides http://www.diagnosticpathology.diagnomx.eu/vs/1381170351801852
%U http://www.diagnosticpathology.org/content/8/1/7/abstract